Introgen Therapeutics Report issue

For profit Phase 2 Phase 3
Founded: Austin TX United States (1993)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
2002
NCT00044993
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now